Iroko Pharmaceuticals ^Companies

Iroko Pharmaceuticals is a global specialty pharmaceutical company that focuses on advancing the science of analgesia. Since its establishment in 2007, Iroko has built a portfolio of proven pharmaceuticals, particularly prescription pain medicines. The company's main goal is to expand the reach of these trusted products by entering new markets, exploring new indications, and leveraging new technology for further development. With a distribution and sales network spanning over 40 countries, Iroko has established a global presence. Additionally, the company is known for its industry-leading pipeline of nano-formulated lower-dose NSAIDs, which aim to provide new options in pain management.